Navigation Links
Air Methods Reports 2Q2009 Results and 3Q2009 Update

DENVER, Aug. 6 /PRNewswire-FirstCall/ -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, reported financial results for the second quarter ended June 30, 2009 and provided an update on July 2009 flight volumes. For the quarter, revenue increased slightly from $128.0 million to $128.1 million in the current-year quarter. For the six-month period, revenue increased 3% to 252.8 million, compared with $246.1 million in the prior-year six-month period.

For the quarter, net income increased 79% to $8.7 million, or $0.70 per diluted share, as compared with prior-year quarter net income of $4.8 million, or $0.38 per diluted share. Net income for the six-month period increased 90% to $13.6 million, or $1.11 per diluted share, compared to $7.2 million, or $0.57 per diluted share, for the prior-year six-month period.

The increase in net income was primarily attributed to decreases in fuel and maintenance expenditures which improved margins in both services divisions, as well as to reductions in general and administrative costs. In addition, the current-year quarter benefited from improved contributions from revenue growth within the Products Division. Maintenance expense decreased by $3.0 million or 13%, while maintenance expense per flight hour decreased by 9% to $561 as compared with the prior-year quarter. Fuel expense decreased $2.7 million or 49% during the quarter, while fuel costs per patient transport decreased 42% to $241 compared with the prior-year quarter. Second quarter general and administrative costs decreased by $2.4 million, or 14%, due to non-recurrence of Federal Aviation Administration operating certificate consolidation costs incurred in the prior-year quarter and efficiencies achieved through reorganization and consolidation of field and corporate overhead functions. Contribution to pre-tax earnings from external revenue within the Products Division increased by $0.9 million during the quarter, as compared with the prior-year period. The current year quarter included pre-tax gains on disposition of aircraft of $0.6 million, compared with $0.1 million in the prior-year period.

For the second quarter, community-based revenue decreased 8% to $71.8 million compared to $77.9 million in the prior year, while segment net income increased 3% to $11.5 million from $11.2 million. Total community-based patient transports were 10,414, as compared with 11,638 in the prior-year quarter. Community-based patient transports for bases open greater than one year (Same-Base Transports) decreased 9%, or 922 patient transports, as compared with the prior-year quarter. Weather cancellations for these same base locations increased by 307 compared with the prior-year quarter. Net revenue per community-based transport was $6,969 for the current-year quarter, compared with $6,727 in the prior-year quarter, a 4% increase. Hospital-based revenue increased 7% to $50.5 million compared to $47.0 million in the prior-year period, while segment net income increased to $5.4 million from $1.1 million. External revenue within the Products Division increased $2.7 million, or 85%, compared with the prior-year quarter.

The Company also provided an update on July 2009 flight volume. Total community-based transports were 3,867 during July 2009 compared with 3,760 in July 2008, a 3% increase. Daily average community-based transports in July 2009 represent a 6% increase over the daily average in June 2009. Same-Base Transports during the month of July increased by 31 transports, or 1%, as compared with July 2008, while weather cancellations decreased by 141 as compared with the prior-year month.

Aaron Todd, CEO, stated, "We are obviously pleased with the continuation of strong growth in earnings through the second quarter of 2009. Significant reductions in maintenance expenditures during our second quarter offer additional confirmation that our fleet rejuvenation efforts and conversion of twin-engine aircraft to more efficient single-engine helicopters are producing anticipated cost reductions. Reductions in our administrative overhead during the economic downturn have contributed to improved net margins, as well."

Mr. Todd added, "Although net revenue per community-based transport for the second quarter was slightly lower than our first quarter results, net revenue per transport for June 2009 was in-line with first quarter reimbursement levels. July 2009 collections continued the healthy pace set in June, as well. These strong July collections, combined with a 5% price increase in our gross charge structure effective July 1st, should have a positive influence on our pending July net revenue per patient transport results. Severe weather patterns during May and June contributed to higher weather cancellations, as well as reduced overall demand. We are pleased by the improved patient flight volumes in July with the return of more moderate summer weather patterns."

The Company will discuss these results in a conference call scheduled today at 4:15 p.m. Eastern. Interested parties can access the call by dialing (877) 883-0656 (domestic) or (706) 643-8826 (international) or by accessing the web cast at A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 22388781, for 3 days following the call and the web cast can be accessed at for 30 days.

Air Methods Corporation ( is a leader in emergency air medical transportation and medical services. The Hospital-Based Services Division is the largest provider of air medical transport services for hospitals. The Community-Based Services Division is the largest community-based provider of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.

Forward Looking Statements: This news release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's air medical services and products markets; the collection rates for patient transports; the continuation and/or renewal of air medical service contracts; the acquisition of profitable Products Division contracts and other flight service operations; the successful expansion of the community-based operations; and other matters set forth in the Company's public filings.

CONTACTS: Aaron D. Todd, Chief Executive Officer, (303) 792-7413 or Trent Carman, Chief Financial Officer, at (303) 792-7591. Please contact Christine Clarke at (303) 792-7579 to be included on the Company's fax and/or mailing list.


                                                  June 30,  December 31,
                                                     2009        2008
                                                  --------- ------------


    Current assets:
    Cash and cash equivalents                       $10,770       13,147
    Trade receivables, net                          123,852      133,467
    Other current assets                             55,023       61,134
                                                     ------       ------

    Total current assets                            189,645      207,748

    Net property and equipment                      157,711      146,167
    Other assets, net                                39,970       41,009
                                                     ------       ------

    Total assets                                   $387,326      394,924
                                                   ========      =======


    Current liabilities:
    Notes payable related to assets held for sale    $4,291       19,520
    Current portion of indebtedness                  16,702       15,638
    Accounts payable, accrued expenses and other     55,957       56,628
                                                     ------       ------

    Total current liabilities                        76,950       91,786

    Long-term indebtedness                           75,526       85,858
    Other non-current liabilities                    56,768       56,816
                                                     ------       ------

    Total liabilities                               209,244      234,460

    Total stockholders' equity                      178,082      160,464
                                                    -------      -------

    Total liabilities and stockholders' equity     $387,326      394,924
                                                   ========      =======

                                 Three Months Ended       Six Months Ended
                                      June 30,                June 30,
                                  ----------------        ----------------
                                  2009        2008        2009        2008
                                  ----        ----        ----        ----

    Flight operations           $122,180     124,746     239,194     239,219
    Product operations             5,920       3,213      13,569       6,839
                                   -----       -----      ------       -----
    Total revenue                128,100     127,959     252,763     246,058
                                 -------     -------     -------     -------

    Operating expenses            94,700      97,496     188,907     190,783
    Gain on disposition
     of assets, net                 (604)       (130)       (533)     (1,438)
    General and administrative    15,167      17,578      32,410      34,724
    Depreciation and
     amortization                  4,629       4,202       9,218       8,300
                                   -----       -----       -----       -----
                                 113,892     119,146     230,002     232,369
                                 -------     -------     -------     -------

    Operating income              14,208       8,813      22,761      13,689

    Interest expense              (1,123)     (1,106)     (2,358)     (2,673)
    Other, net                       941         609       1,763       1,252
                                     ---         ---       -----       -----

    Income before income taxes    14,026       8,316      22,166      12,268

    Income tax expense            (5,374)     (3,482)     (8,526)     (5,104)
                                  ------      ------      ------      ------

    Net income                    $8,652       4,834      13,640       7,164
                                  ======       =====      ======       =====

    Income per common share:
       Basic                       $0.71        0.40        1.12        0.59
       Diluted                     $0.70        0.38        1.11        0.57

    Weighted average
     common shares
     outstanding - basic      12,226,948  12,181,790  12,158,010  12,166,566
    Weighted average
     common shares
     outstanding - diluted    12,403,400  12,608,043  12,342,126  12,617,804

SOURCE Air Methods Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
2. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
3. GPS-like technology helps pinpoint best methods for moving injured players
4. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
5. Manchester researchers announce new methods of beating breast cancer
6. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
7. Air Methods to Report Third Quarter Financial Results Before Market Open on Thursday, November 8, 2007
8. Air Methods Reports 3Q2007 Results and 4Q2007 Update
9. New Booklet Reveals 12 Proven Methods for Stopping MRSA from Infecting Your Feet and Your Familys Feet
10. Cold Spring Harbor Protocols features innovative methods for embryology research
11. Results promising for computational quantum chemical methods for drug development
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... most successful and prominent nonprofit healthcare organizations in the country. They have overseen ... various organizations, and helped advance the healthcare industry as a whole through their ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... Jobs in ... by healthcare professionals and offered by healthcare staffing agency Aureus Medical Group . ... the month of October 2015 among those searching for healthcare jobs through the company’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack ... trailer titles work with any font, giving users limitless opportunities to stylize and ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology: